L-Histidine,beta-alanyl-;L-Carnosine (beta-Alanyl-L-histidine);β-Ala-His-OH;L-Carnosine,N-beta-Alanyl-L-histidine;H-BETA-ALA-HIS-OH;L-IGNOTINE;L-BETA-ALANINE HISTIDINE;L-CARNOSINE
CAS:305-84-0
Chemical Formula:C9H14N4O3
Molecular Weight:226.23
Availability: R&D; Commercialization
⬤ CAS No.305-84-0
⬤ Packaging type：20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| Product Name | L-Carnosine |
| CAS No. | 305-84-0 |
| Chemical Formula | C9H14N4O3 |
| Molecular Weight | 226.23 |
| Related Categories | Fine Chemicals |
| Storage Conditions | -20°C |
| Melting Point | 253 °C (dec.) (lit.) |
| Boiling Point | 367.84°C (rough estimate) |
| Specific rotation | 20.9 º (c=1.5, H2O) |
| Density | 1.2673 (rough estimate) |
| Color | White |
| Odor | Odorless |
| optical activity | +24.120 |
| Water solubility | almost transparency |
| stability | Stable but may be heat sensitive – refrigerate. Incompatible with strong oxidizing agents |
| Storage and transportation characteristics | Low temperature, ventilation and drying of the warehouse |
| Hazardous characteristics | Thermal decomposition emits toxic nitrogen oxide fumes |
| Application | This product (L-Carnosine, CAS 305-84-0) is a pharmaceutical intermediate and is limited to: – Drug synthesis process research and development – In vitro experimental research. Not suitable for direct human use, food additives or consumer end products. |
Reliable Global Partner
“Tianming Pharmaceutical has redefined reliability for us. Their ability to deliver high-potency APIs and intermediates under tight deadlines—is unmatched. The team’s transparency in documentation and proactive updates make them a stress-free partner. A true backbone for our operations!”
March 18, 2024
Outstanding Technical Guidance
“Few suppliers align so perfectly with EU GMP requirements. Tianming’s commitment to audit-ready quality systems, batch traceability, and purity consistency has streamlined our production processes. Their diligence eliminates regulatory risks—a rare advantage in today’s market.”
February 15, 2024
Beyond Supplier, A Solutions Partner
“Tianming’s technical team doesn’t just deliver materials—they solve problems. When we faced stability challenges with a niche compound, their scientists proposed a tailored purity adjustment that saved our project timeline. Their agility transforms obstacles into opportunities.”
June 15, 2024
Strategic Growth Ally
“Over 5+ years, Tianming has consistently adapted to our evolving needs—whether scaling volumes or supporting custom synthesis projects. Their ethical pricing models and long-term vision make them more than a vendor; they’re integral to our competitive edge.”
April 27, 2024
Brigatinib manufacturer guide: Takeda (brand), Lonza (CDMO), and 72+ API vendors. Patent expiries: China 2026, US 2035. How to choose a reliable supplier for generic development.
This article summarizes 2025 latest research on ibrutinib’s long-term side effects, covering atrial fibrillation, bleeding, hypertension, infections and joint issues. It compares safety with newer BTK inhibitors and notes real-world treatment discontinuation risks.
Orforglipron vs retatrutide: oral small‑molecule GLP‑1 agonist vs triple‑hormone injectable. Phase 3 weight loss data, dosing schedules, side effects, regulatory status, and API manufacturing differences.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
